Is It Too Late to Invest in Eli Lilly? Over 400% Years
Eli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
Wondering which is better: cash back or points credit card? Explore the pros and cons to choose the right card for your needs.
27,103 articlesEli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...
Market fear is loud, but smart investors look for resilient opportunities. Here’s why I’m adding a tech stock to my p...
Two of the biggest names in cybersecurity, CrowdStrike and Palo Alto Networks, have shaped how companies guard their ...
Delek Logistics Partners has logged 13 years of rising payouts, but 2025 cash flow barely covers distributions, promp...
A new warning about looming physical oil shortages is sending ripples through energy stocks. This article explains wh...
Looking for a long-term growth plan? This article highlights three growth stocks to hold next for the next two decade...
When a tech titan speaks, markets listen. This article breaks down NVIDIA's latest signals from the GTC AI conference...
A notable $25.7 million position in DNOW signals institutional confidence despite an 18% drop last year. This article...
Intel posted a stronger-than-expected Q1, yet rising costs and cash-flow strain raise the risk of a sharper pullback....
Palantir stock slipped from its peak, triggering questions about value, risk, and timing for late 2026. This guide br...
ECL, EMN, and BCC report mixed quarters as 2026 guidance and cost actions set the tone for a volatile chemicals secto...